BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 31623618)

  • 1. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
    Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
    Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1.
    Kim S; Song G; Lee T; Kim M; Kim J; Kwon H; Kim J; Jeong W; Lee U; Na C; Kang S; Kim W; Seong JK; Jho EH
    Cell Death Differ; 2021 Sep; 28(9):2555-2570. PubMed ID: 33753903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Sitosterol blocks the LEF-1-mediated Wnt/β-catenin pathway to inhibit proliferation of human colon cancer cells.
    Gu S; Liu F; Xie X; Ding M; Wang Z; Xing X; Xiao T; Sun X
    Cell Signal; 2023 Apr; 104():110585. PubMed ID: 36603684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
    Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
    PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.
    Chan SC; Hajarnis SS; Vrba SM; Patel V; Igarashi P
    J Biol Chem; 2020 Dec; 295(51):17560-17572. PubMed ID: 33453998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
    Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
    Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
    Lee Y; Piao HL; Kim J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor Lef1 switches partners from β-catenin to Smad3 during muscle stem cell quiescence.
    Aloysius A; DasGupta R; Dhawan J
    Sci Signal; 2018 Jul; 11(540):. PubMed ID: 30042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
    Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
    J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
    Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of NGX6 in Wnt/β-catenin signaling pathway in colon cancer].
    Liu F; Sheng S; Wang X; Peng Y; Guo Q; Xiao Z; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):235-42. PubMed ID: 21464545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
    Hovanes K; Li TW; Munguia JE; Truong T; Milovanovic T; Lawrence Marsh J; Holcombe RF; Waterman ML
    Nat Genet; 2001 May; 28(1):53-7. PubMed ID: 11326276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
    Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
    Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.